Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

4(57.1%)

Phase 1

1(14.3%)

Phase 3

1(14.3%)

Phase 4

1(14.3%)

7Total

N/A(4)

Phase 1(1)

Phase 3(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07382856Not ApplicableActive Not Recruiting

Effect of Low-intensity Aerobic Regular Activity on Heart Rate Variability in Type 1 Diabetes

Role: lead

NCT07072949Phase 1Completed

The Impact of Ursodeoxycholic Acid and Probiotics on Metabolic Outcomes in Type 2 Diabetic Patients Taking Metformin

Role: lead

NCT06475586Phase 4Completed

Effect of Semaglutide on the Psoriatic Lesions in Patients With Type 2 Diabetes Mellitus

Role: lead

NCT05915117Not ApplicableUnknown

Effects of Polyphenols of Pomegranate Fruit Peel Extract on Inflammation and Oxidative Stress in Metabolic Syndrome

Role: lead

NCT05416580Phase 3Unknown

Efficacy of Ursodeoxycholic Acid (UDCA) in Patients With Type 2 Diabetes

Role: lead

NCT05853770Not ApplicableCompleted

Effects of Volleyball Intervention on Health-related Fitness in Primary School Students

Role: collaborator

NCT05001906Not ApplicableCompleted

Pregnant Women With Physical Activity

Role: lead

All 7 trials loaded